Biometrics Leader LifeQ Revolutionizes Healthcare with Disease Screening and Early Detection
Retrieved on:
Monday, March 20, 2023
Mont Blanc, Fossil, Blood pressure, Medicine, Night, Probability, Photoplethysmogram, Cardiomyopathy, TAG Heuer, Health, Bradycardia, Classification, HOCM, Atrial fibrillation, Respiratory rate, COVID-19, Sleep, Restless legs syndrome, Arteriosclerosis, Narcolepsy, Sleep apnea, Acute (medicine), Tachycardia, Hypersomnia, Hypertension, Aortic stenosis, Insomnia, PLMD, Patient, Rapid eye movement sleep behavior disorder, Physician, Cardiovascular disease, PPG, Korea Disease Control and Prevention Agency, Diagnosis, Heart rate, Skin temperature, Chronic condition, Sleepwalking, Bigeminy, Conditional sentence, Disease, REM, Pharmaceutical industry, Medical device, Suunto
ATLANTA, March 20, 2023 /PRNewswire/ -- LifeQ, the company that uses globally-recognized watch brands to gather personalized, clinical-grade data, announced it can detect as many as 40 sleep and cardiovascular disorders with smart watches and other wearable devices, with an anticipated 100 diseases and disorders within the next two years—revolutionizing healthcare and improving consumers' lives. LifeQ co-founders Laurence (Laurie) Olivier, CEO, and Dr. Franco du Preez, Chief Science Officer, made the announcement.
Key Points:
- LifeQ co-founders Laurence (Laurie) Olivier, CEO, and Dr. Franco du Preez, Chief Science Officer, made the announcement.
- LifeQ-enabled devices will help busy clinicians to detect important medical conditions, enable data-driven disease classification as well as facilitate disease prevention.
- Screening for and flagging disease using wearables is possible through LifeQ's unique combination of photoplethysmography (PPG) and computational systems biology approach.
- Wearable devices will soon enable insights for hundreds of diseases, providing a personalized action plan and a truly preventative approach to healthcare.